Skip to content
Home/Companies/Pharma/PrioThera
PrioThera

PrioThera

Pharma·Ireland·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns PrioThera?

PrioThera is an Irish Pharma company, currently owned by Earlybird Venture Capital since 2020.

Hand-verified · updated 2026-08-10

Open JSON · CC-BY
Earlybird Venture Capital
Investor
Earlybird Venture Capital
Earlybird Health · 2017 · VC

Key facts

HQIreland
SectorPharma
StatusActive
Websitepriothera.com

More from Earlybird Health

Other portfolio companies in the same fund.

Axon Vascular Europe
Active
MedTechUK· 2025
Haya Therapeutics
Haya Therapeutics
Active
BiotechSwitzerland· 2025
Hilo
Hilo
Active
MedTechSwitzerland· 2025
Portal Biotech
Active
BiotechUK· 2025
Rivia
Active
HealthTechSwitzerland· 2025
Gemma Biotherapeutics
Gemma Biotherapeutics
Active
BiotechUS· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns PrioThera?

PrioThera is currently owned by Earlybird Venture Capital, through Earlybird Health, since 2020.

When did Earlybird Venture Capital acquire PrioThera?

Earlybird Venture Capital acquired PrioThera in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue